ID   CALX_HUMAN              Reviewed;         592 AA.
AC   P27824; B2R5V8; B4DGP8; B4E2T8; D3DWQ3; D6R9K3;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 2.
DT   28-JAN-2026, entry version 252.
DE   RecName: Full=Calnexin;
DE   AltName: Full=IP90;
DE   AltName: Full=Major histocompatibility complex class I antigen-binding protein p88;
DE   AltName: Full=p90;
DE   Flags: Precursor;
GN   Name=CANX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8486646; DOI=10.1016/s0021-9258(18)98391-2;
RA   David V., Hochstenbach F., Rajagopalan S., Brenner M.B.;
RT   "Interaction with newly synthesized and retained proteins in the
RT   endoplasmic reticulum suggests a chaperone function for human integral
RT   membrane protein IP90 (calnexin).";
RL   J. Biol. Chem. 268:9585-9592(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lymph, and Placenta;
RX   PubMed=8136357; DOI=10.1021/bi00177a013;
RA   Tjoelker L.W., Seyfried C.E., Eddy R.L. Jr., Shows T.B. Jr., Calderon J.,
RA   Schreiber R.B., Gray P.W.;
RT   "Human, mouse, and rat calnexin cDNA cloning: identification of potential
RT   calcium binding motifs and gene localization to human chromosome 5.";
RL   Biochemistry 33:3229-3236(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Keratinocyte;
RX   PubMed=8055875; DOI=10.1002/elps.1150150166;
RA   Honore B., Rasmussen H.H., Celis A., Leffers H., Madsen P., Celis J.E.;
RT   "The molecular chaperones HSP28, GRP78, endoplasmin, and calnexin exhibit
RT   strikingly different levels in quiescent keratinocytes as compared to their
RT   proliferating normal and transformed counterparts: cDNA cloning and
RT   expression of calnexin.";
RL   Electrophoresis 15:482-490(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fibroblast;
RA   Hansen J.J., Jorgensen M.M., Bolund L., Gregersen N.;
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Brain, Cerebellum, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 62-77; 171-193; 200-205; 221-227; 401-415; 517-525 AND
RP   574-582, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (MAR-2005) to UniProtKB.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 237-592 (ISOFORM 1).
RX   PubMed=1326756; DOI=10.1073/pnas.89.18.8452;
RA   Galvin K., Krishna S., Ponchel F., Frohlich M., Cummings D.E., Carlson R.,
RA   Wands J.R., Isselbacher K.J., Pillai S., Ozturk M.;
RT   "The major histocompatibility complex class I antigen-binding protein p88
RT   is the product of the calnexin gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:8452-8456(1992).
RN   [11]
RP   PROTEIN SEQUENCE OF 275-286; 293-313; 383-398 AND 516-523.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel protein
RT   database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [12]
RP   INTERACTION WITH HBV LARGE ENVELOPE PROTEIN ISOFORM L (MICROBIAL
RP   INFECTION).
RX   PubMed=9188622; DOI=10.1128/jvi.71.7.5487-5494.1997;
RA   Xu Z., Bruss V., Yen T.S.;
RT   "Formation of intracellular particles by hepatitis B virus large surface
RT   protein.";
RL   J. Virol. 71:5487-5494(1997).
RN   [13]
RP   INTERACTION WITH HBV LARGE ENVELOPE PROTEIN ISOFORM M (MICROBIAL
RP   INFECTION).
RX   PubMed=9420286; DOI=10.1128/jvi.72.1.778-782.1998;
RA   Werr M., Prange R.;
RT   "Role for calnexin and N-linked glycosylation in the assembly and secretion
RT   of hepatitis B virus middle envelope protein particles.";
RL   J. Virol. 72:778-782(1998).
RN   [14]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=12643545; DOI=10.1021/pr025562r;
RA   Basrur V., Yang F., Kushimoto T., Higashimoto Y., Yasumoto K., Valencia J.,
RA   Muller J., Vieira W.D., Watabe H., Shabanowitz J., Hearing V.J., Hunt D.F.,
RA   Appella E.;
RT   "Proteomic analysis of early melanosomes: identification of novel
RT   melanosomal proteins.";
RL   J. Proteome Res. 2:69-79(2003).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-554 AND SER-583, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [16]
RP   INTERACTION WITH KCNH2.
RX   PubMed=16361248; DOI=10.1074/jbc.m511765200;
RA   Gong Q., Jones M.A., Zhou Z.;
RT   "Mechanisms of pharmacological rescue of trafficking-defective hERG mutant
RT   channels in human long QT syndrome.";
RL   J. Biol. Chem. 281:4069-4074(2006).
RN   [17]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J.,
RA   Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S.,
RA   Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-554 AND SER-583, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-554 AND SER-583, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-554 AND SER-564, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-554, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-564, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [24]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-137, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [25]
RP   INTERACTION WITH PPIB.
RX   PubMed=20801878; DOI=10.1074/jbc.m110.160101;
RA   Kozlov G., Bastos-Aristizabal S., Maattanen P., Rosenauer A., Zheng F.,
RA   Killikelly A., Trempe J.F., Thomas D.Y., Gehring K.;
RT   "Structural basis of cyclophilin B binding by the calnexin/calreticulin P-
RT   domain.";
RL   J. Biol. Chem. 285:35551-35557(2010).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-554; SER-564 AND SER-583, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [28]
RP   INTERACTION WITH ZNRF4, AND UBIQUITINATION.
RX   PubMed=21205830; DOI=10.1074/jbc.m110.197459;
RA   Neutzner A., Neutzner M., Benischke A.S., Ryu S.W., Frank S., Youle R.J.,
RA   Karbowski M.;
RT   "A systematic search for endoplasmic reticulum (ER) membrane-associated
RT   RING finger proteins identifies Nixin/ZNRF4 as a regulator of calnexin
RT   stability and ER homeostasis.";
RL   J. Biol. Chem. 286:8633-8643(2011).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-554; THR-562 AND SER-583, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [30]
RP   PALMITOYLATION AT CYS-502 AND CYS-503 BY DHHC6, SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH SSR1.
RX   PubMed=22314232; DOI=10.1038/emboj.2012.15;
RA   Lakkaraju A.K., Abrami L., Lemmin T., Blaskovic S., Kunz B., Kihara A.,
RA   Dal Peraro M., van der Goot F.G.;
RT   "Palmitoylated calnexin is a key component of the ribosome-translocon
RT   complex.";
RL   EMBO J. 31:1823-1835(2012).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-554; THR-562; SER-564 AND
RP   SER-583, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [32]
RP   INTERACTION WITH SERPINA2P AND SERPINA1, AND SUBCELLULAR LOCATION.
RX   PubMed=23826168; DOI=10.1371/journal.pone.0066889;
RA   Marques P.I., Ferreira Z., Martins M., Figueiredo J., Silva D.I.,
RA   Castro P., Morales-Hojas R., Simoes-Correia J., Seixas S.;
RT   "SERPINA2 is a novel gene with a divergent function from SERPINA1.";
RL   PLoS ONE 8:E66889-E66889(2013).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-554; THR-562; SER-564 AND
RP   SER-583, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [34]
RP   INTERACTION WITH DNM1L.
RX   PubMed=24196833; DOI=10.1091/mbc.e13-09-0525;
RA   Shen Q., Yamano K., Head B.P., Kawajiri S., Cheung J.T., Wang C., Cho J.H.,
RA   Hattori N., Youle R.J., van der Bliek A.M.;
RT   "Mutations in Fis1 disrupt orderly disposal of defective mitochondria.";
RL   Mol. Biol. Cell 25:145-159(2014).
RN   [35]
RP   CLEAVAGE OF SIGNAL PEPTIDE [LARGE SCALE ANALYSIS] AFTER ALA-20, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [36]
RP   INTERACTION WITH SMIM22.
RX   PubMed=29765154; DOI=10.1038/s41388-018-0281-5;
RA   Polycarpou-Schwarz M., Gross M., Mestdagh P., Schott J., Grund S.E.,
RA   Hildenbrand C., Rom J., Aulmann S., Sinn H.P., Vandesompele J.,
RA   Diederichs S.;
RT   "The cancer-associated microprotein CASIMO1 controls cell proliferation and
RT   interacts with squalene epoxidase modulating lipid droplet formation.";
RL   Oncogene 37:4750-4768(2018).
RN   [37]
RP   INTERACTION WITH TMX2.
RX   PubMed=31735293; DOI=10.1016/j.ajhg.2019.10.009;
RA   Vandervore L.V., Schot R., Milanese C., Smits D.J., Kasteleijn E.,
RA   Fry A.E., Pilz D.T., Brock S., Boerklue-Yuecel E., Post M.,
RA   Bahi-Buisson N., Sanchez-Soler M.J., van Slegtenhorst M., Keren B.,
RA   Afenjar A., Coury S.A., Tan W.H., Oegema R., de Vries L.S., Fawcett K.A.,
RA   Nikkels P.G.J., Bertoli-Avella A., Al Hashem A., Alwabel A.A.,
RA   Tlili-Graiess K., Efthymiou S., Zafar F., Rana N., Bibi F., Houlden H.,
RA   Maroofian R., Person R.E., Crunk A., Savatt J.M., Turner L., Doosti M.,
RA   Karimiani E.G., Saadi N.W., Akhondian J., Lequin M.H., Kayserili H.,
RA   van der Spek P.J., Jansen A.C., Kros J.M., Verdijk R.M., Milosevic N.J.,
RA   Fornerod M., Mastroberardino P.G., Mancini G.M.S.;
RT   "TMX2 is a crucial regulator of cellular redox state, and its dysfunction
RT   causes severe brain developmental abnormalities.";
RL   Am. J. Hum. Genet. 105:1126-1147(2019).
RN   [38]
RP   INTERACTION WITH CHRNA7.
RX   PubMed=32783947; DOI=10.1016/j.celrep.2020.108025;
RA   Kweon H.J., Gu S., Witham E., Dhara M., Yu H., Mandon E.D., Jawhari A.,
RA   Bredt D.S.;
RT   "NACHO Engages N-Glycosylation ER Chaperone Pathways for alpha7 Nicotinic
RT   Receptor Assembly.";
RL   Cell Rep. 32:108025-108025(2020).
RN   [39]
RP   INTERACTION WITH RETREG2 AND RETREG3.
RX   PubMed=34338405; DOI=10.15252/embr.202052289;
RA   Reggio A., Buonomo V., Berkane R., Bhaskara R.M., Tellechea M., Peluso I.,
RA   Polishchuk E., Di Lorenzo G., Cirillo C., Esposito M., Hussain A.,
RA   Huebner A.K., Huebner C.A., Settembre C., Hummer G., Grumati P., Stolz A.;
RT   "Role of FAM134 paralogues in endoplasmic reticulum remodeling, ER-phagy,
RT   and Collagen quality control.";
RL   EMBO Rep. 22:e52289-e52289(2021).
CC   -!- FUNCTION: Calcium-binding protein that interacts with newly synthesized
CC       monoglucosylated glycoproteins in the endoplasmic reticulum. It may act
CC       in assisting protein assembly and/or in the retention within the ER of
CC       unassembled protein subunits. It seems to play a major role in the
CC       quality control apparatus of the ER by the retention of incorrectly
CC       folded proteins. Associated with partial T-cell antigen receptor
CC       complexes that escape the ER of immature thymocytes, it may function as
CC       a signaling complex regulating thymocyte maturation. Additionally it
CC       may play a role in receptor-mediated endocytosis at the synapse.
CC   -!- SUBUNIT: Interacts with MAPK3/ERK1 (By similarity). Interacts with
CC       KCNH2 (PubMed:16361248). Associates with ribosomes (By similarity).
CC       Interacts with SGIP1; involved in negative regulation of endocytosis
CC       (By similarity). The palmitoylated form interacts with the ribosome-
CC       translocon complex component SSR1, promoting efficient folding of
CC       glycoproteins (PubMed:22314232). Interacts with SERPINA2P/SERPINA2 and
CC       with the S and Z variants of SERPINA1 (PubMed:23826168). Interacts with
CC       PPIB (PubMed:20801878). Interacts with ZNRF4 (PubMed:21205830).
CC       Interacts with SMIM22 (PubMed:29765154). Interacts with TMX2
CC       (PubMed:31735293). Interacts with TMEM35A/NACHO (By similarity).
CC       Interacts with CHRNA7 (PubMed:32783947). Interacts with reticulophagy
CC       regulators RETREG2 and RETREG3 (PubMed:34338405). Interacts with DNM1L;
CC       may form part of a larger protein complex at the ER-mitochondrial
CC       interface during mitochondrial fission (PubMed:24196833). Interacts
CC       with ADAM7 (By similarity). {ECO:0000250|UniProtKB:P35564,
CC       ECO:0000250|UniProtKB:P35565, ECO:0000269|PubMed:16361248,
CC       ECO:0000269|PubMed:20801878, ECO:0000269|PubMed:21205830,
CC       ECO:0000269|PubMed:22314232, ECO:0000269|PubMed:23826168,
CC       ECO:0000269|PubMed:29765154, ECO:0000269|PubMed:31735293,
CC       ECO:0000269|PubMed:32783947, ECO:0000269|PubMed:34338405}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HBV large envelope
CC       protein, isoform L. {ECO:0000269|PubMed:9188622}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HBV large envelope
CC       protein, isoform M; this association may be essential for isoform M
CC       proper secretion. {ECO:0000269|PubMed:9188622}.
CC   -!- INTERACTION:
CC       P27824; O95477: ABCA1; NbExp=8; IntAct=EBI-355947, EBI-784112;
CC       P27824; P13569: CFTR; NbExp=27; IntAct=EBI-355947, EBI-349854;
CC       P27824; Q7LFX5: CHST15; NbExp=3; IntAct=EBI-355947, EBI-11123530;
CC       P27824; Q9UHC6-1: CNTNAP2; NbExp=2; IntAct=EBI-355947, EBI-16594440;
CC       P27824; P00387: CYB5R3; NbExp=2; IntAct=EBI-355947, EBI-1046040;
CC       P27824; O00115: DNASE2; NbExp=3; IntAct=EBI-355947, EBI-1051412;
CC       P27824; Q92597: NDRG1; NbExp=2; IntAct=EBI-355947, EBI-716486;
CC       P27824; P41143: OPRD1; NbExp=2; IntAct=EBI-355947, EBI-2624456;
CC       P27824; P30050: RPL12; NbExp=3; IntAct=EBI-355947, EBI-352743;
CC       P27824; P61619: SEC61A1; NbExp=5; IntAct=EBI-355947, EBI-358919;
CC       P27824; P29622: SERPINA4; NbExp=2; IntAct=EBI-355947, EBI-7108503;
CC       P27824; P43307: SSR1; NbExp=7; IntAct=EBI-355947, EBI-714168;
CC       P27824; P11607: ATP2A2; Xeno; NbExp=2; IntAct=EBI-355947, EBI-8004986;
CC       P27824; P04578: env; Xeno; NbExp=3; IntAct=EBI-355947, EBI-6163496;
CC       P27824-2; P05067: APP; NbExp=3; IntAct=EBI-25890990, EBI-77613;
CC       P27824-2; P04271: S100B; NbExp=3; IntAct=EBI-25890990, EBI-458391;
CC       P27824-2; P43405-2: SYK; NbExp=3; IntAct=EBI-25890990, EBI-25892332;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:22314232}; Single-pass type I membrane protein
CC       {ECO:0000255}. Mitochondrion membrane {ECO:0000250|UniProtKB:P24643};
CC       Single-pass type I membrane protein {ECO:0000255}. Melanosome membrane
CC       {ECO:0000269|PubMed:12643545, ECO:0000269|PubMed:17081065}; Single-pass
CC       type I membrane protein {ECO:0000255}. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV
CC       (PubMed:12643545, PubMed:17081065). The palmitoylated form
CC       preferentially localizes to the perinuclear rough ER (PubMed:22314232).
CC       Localizes to endoplasmic reticulum mitochondria-associated membrane
CC       (MAMs) that connect the endoplasmic reticulum and the mitochondria (By
CC       similarity). {ECO:0000250|UniProtKB:P24643,
CC       ECO:0000269|PubMed:12643545, ECO:0000269|PubMed:17081065,
CC       ECO:0000269|PubMed:22314232}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P27824-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P27824-2; Sequence=VSP_055516;
CC       Name=3;
CC         IsoId=P27824-3; Sequence=VSP_055515;
CC   -!- PTM: Phosphorylated at Ser-564 by MAPK3/ERK1. Phosphorylation by
CC       MAPK3/ERK1 increases its association with ribosomes (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Palmitoylation by DHHC6 leads to the preferential localization to
CC       the perinuclear rough ER. It mediates the association of calnexin with
CC       the ribosome-translocon complex (RTC) which is required for efficient
CC       folding of glycosylated proteins. {ECO:0000269|PubMed:22314232}.
CC   -!- PTM: Ubiquitinated, leading to proteasomal degradation. Probably
CC       ubiquitinated by ZNRF4. {ECO:0000269|PubMed:21205830}.
CC   -!- SIMILARITY: Belongs to the calreticulin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Calnexin entry;
CC       URL="https://en.wikipedia.org/wiki/Calnexin";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L10284; AAA36125.1; -; mRNA.
DR   EMBL; L18887; AAA21013.1; -; mRNA.
DR   EMBL; M94859; AAA21749.1; -; mRNA.
DR   EMBL; M98452; AAA35696.1; -; mRNA.
DR   EMBL; AK294702; BAG57859.1; -; mRNA.
DR   EMBL; AK304420; BAG65250.1; -; mRNA.
DR   EMBL; AK312334; BAG35255.1; -; mRNA.
DR   EMBL; AC113426; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC136604; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471165; EAW53802.1; -; Genomic_DNA.
DR   EMBL; CH471165; EAW53803.1; -; Genomic_DNA.
DR   EMBL; CH471165; EAW53805.1; -; Genomic_DNA.
DR   EMBL; BC003552; AAH03552.1; -; mRNA.
DR   EMBL; BC042843; AAH42843.1; -; mRNA.
DR   EMBL; AJ271880; CAB72137.1; -; mRNA.
DR   CCDS; CCDS4447.1; -. [P27824-1]
DR   CCDS; CCDS93840.1; -. [P27824-3]
DR   PIR; A46164; A46164.
DR   PIR; A46673; A46673.
DR   PIR; I53260; I53260.
DR   RefSeq; NP_001019820.1; NM_001024649.2. [P27824-1]
DR   RefSeq; NP_001350923.1; NM_001363994.1. [P27824-2]
DR   RefSeq; NP_001350925.1; NM_001363996.1. [P27824-1]
DR   RefSeq; NP_001350926.1; NM_001363997.1. [P27824-1]
DR   RefSeq; NP_001350929.1; NM_001364000.1. [P27824-3]
DR   RefSeq; NP_001350930.1; NM_001364001.1. [P27824-3]
DR   RefSeq; NP_001737.1; NM_001746.4. [P27824-1]
DR   RefSeq; XP_011532967.1; XM_011534665.4. [P27824-1]
DR   RefSeq; XP_047273748.1; XM_047417792.1. [P27824-1]
DR   RefSeq; XP_054187987.1; XM_054332012.1. [P27824-1]
DR   RefSeq; XP_054187988.1; XM_054332013.1. [P27824-1]
DR   RefSeq; XP_054209564.1; XM_054353589.1. [P27824-1]
DR   AlphaFoldDB; P27824; -.
DR   SMR; P27824; -.
DR   BioGRID; 107271; 1369.
DR   CORUM; P27824; -.
DR   DIP; DIP-457N; -.
DR   FunCoup; P27824; 3512.
DR   IntAct; P27824; 999.
DR   MINT; P27824; -.
DR   STRING; 9606.ENSP00000247461; -.
DR   BindingDB; P27824; -.
DR   ChEMBL; CHEMBL2719; -.
DR   DrugBank; DB00025; Antihemophilic factor, human recombinant.
DR   DrugBank; DB11093; Calcium citrate.
DR   DrugBank; DB11348; Calcium Phosphate.
DR   DrugBank; DB14481; Calcium phosphate dihydrate.
DR   DrugBank; DB06245; Lanoteplase.
DR   DrugBank; DB13998; Lonoctocog alfa.
DR   DrugBank; DB13999; Moroctocog alfa.
DR   TCDB; 8.A.165.1.1; the calnexin (calnexin) family.
DR   GlyCosmos; P27824; 3 sites, 2 glycans.
DR   GlyGen; P27824; 10 sites, 1 N-linked glycan (1 site), 4 O-linked glycans (8 sites).
DR   iPTMnet; P27824; -.
DR   PhosphoSitePlus; P27824; -.
DR   SwissPalm; P27824; -.
DR   BioMuta; CANX; -.
DR   DMDM; 543920; -.
DR   jPOST; P27824; -.
DR   MassIVE; P27824; -.
DR   PaxDb; 9606-ENSP00000247461; -.
DR   PeptideAtlas; P27824; -.
DR   PRIDE; P27824; -.
DR   ProteomicsDB; 54425; -. [P27824-1]
DR   ProteomicsDB; 5850; -.
DR   Pumba; P27824; -.
DR   TopDownProteomics; P27824-1; -. [P27824-1]
DR   ABCD; P27824; 1 sequenced antibody.
DR   Antibodypedia; 2421; 1183 antibodies from 46 providers.
DR   DNASU; 821; -.
DR   Ensembl; ENST00000247461.9; ENSP00000247461.4; ENSG00000127022.17. [P27824-1]
DR   Ensembl; ENST00000452673.6; ENSP00000391646.2; ENSG00000127022.17. [P27824-1]
DR   Ensembl; ENST00000502296.6; ENSP00000424745.2; ENSG00000127022.17. [P27824-1]
DR   Ensembl; ENST00000504734.5; ENSP00000424063.1; ENSG00000127022.17. [P27824-1]
DR   Ensembl; ENST00000506654.6; ENSP00000426555.2; ENSG00000127022.17. [P27824-3]
DR   Ensembl; ENST00000509563.2; ENSP00000421434.2; ENSG00000127022.17. [P27824-1]
DR   Ensembl; ENST00000513246.6; ENSP00000421813.2; ENSG00000127022.17. [P27824-1]
DR   Ensembl; ENST00000638425.1; ENSP00000492372.1; ENSG00000283777.2. [P27824-1]
DR   Ensembl; ENST00000638706.2; ENSP00000492868.1; ENSG00000283777.2. [P27824-1]
DR   Ensembl; ENST00000639938.1; ENSP00000491760.1; ENSG00000283777.2. [P27824-1]
DR   Ensembl; ENST00000680006.1; ENSP00000505129.1; ENSG00000127022.17. [P27824-3]
DR   Ensembl; ENST00000680013.1; ENSP00000506078.1; ENSG00000127022.17. [P27824-1]
DR   Ensembl; ENST00000680042.1; ENSP00000505960.1; ENSG00000127022.17. [P27824-1]
DR   Ensembl; ENST00000680092.1; ENSP00000505202.1; ENSG00000127022.17. [P27824-1]
DR   Ensembl; ENST00000680618.1; ENSP00000506583.1; ENSG00000127022.17. [P27824-1]
DR   Ensembl; ENST00000680827.1; ENSP00000506051.1; ENSG00000127022.17. [P27824-3]
DR   Ensembl; ENST00000681072.1; ENSP00000505526.1; ENSG00000127022.17. [P27824-1]
DR   Ensembl; ENST00000681168.1; ENSP00000506021.1; ENSG00000127022.17. [P27824-1]
DR   Ensembl; ENST00000681476.1; ENSP00000506003.1; ENSG00000127022.17. [P27824-1]
DR   Ensembl; ENST00000681674.1; ENSP00000505013.1; ENSG00000127022.17. [P27824-1]
DR   Ensembl; ENST00000681712.1; ENSP00000506061.1; ENSG00000127022.17. [P27824-1]
DR   Ensembl; ENST00000681733.1; ENSP00000506568.1; ENSG00000127022.17. [P27824-1]
DR   Ensembl; ENST00000681903.1; ENSP00000506509.1; ENSG00000127022.17. [P27824-1]
DR   GeneID; 821; -.
DR   KEGG; hsa:821; -.
DR   MANE-Select; ENST00000247461.9; ENSP00000247461.4; NM_001746.4; NP_001737.1.
DR   UCSC; uc003mkk.4; human. [P27824-1]
DR   AGR; HGNC:1473; -.
DR   ClinPGx; PA26055; -.
DR   CTD; 821; -.
DR   DisGeNET; 821; -.
DR   GeneCards; CANX; -.
DR   HGNC; HGNC:1473; CANX.
DR   HPA; ENSG00000127022; Low tissue specificity.
DR   MIM; 114217; gene.
DR   OpenTargets; ENSG00000127022; -.
DR   VEuPathDB; HostDB:ENSG00000127022; -.
DR   eggNOG; KOG0675; Eukaryota.
DR   GeneTree; ENSGT00950000182915; -.
DR   HOGENOM; CLU_018224_2_0_1; -.
DR   InParanoid; P27824; -.
DR   OMA; QWEVDEM; -.
DR   OrthoDB; 1938156at2759; -.
DR   PAN-GO; P27824; 4 GO annotations based on evolutionary models.
DR   PhylomeDB; P27824; -.
DR   PathwayCommons; P27824; -.
DR   Reactome; R-HSA-168316; Assembly of Viral Components at the Budding Site.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-8984722; Interleukin-35 Signalling.
DR   Reactome; R-HSA-901042; Calnexin/calreticulin cycle.
DR   Reactome; R-HSA-9020956; Interleukin-27 signaling.
DR   Reactome; R-HSA-9683686; Maturation of spike protein.
DR   Reactome; R-HSA-9694548; Maturation of spike protein.
DR   Reactome; R-HSA-9768727; Regulation of CDH1 posttranslational processing and trafficking to plasma membrane.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   SignaLink; P27824; -.
DR   Agora; ENSG00000127022; -.
DR   BioGRID-ORCS; 821; 18 hits in 1165 CRISPR screens.
DR   ChiTaRS; CANX; human.
DR   GeneWiki; Calnexin; -.
DR   GenomeRNAi; 821; -.
DR   Pharos; P27824; Tbio.
DR   PRO; PR:P27824; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; P27824; protein.
DR   Bgee; ENSG00000127022; Expressed in stromal cell of endometrium and 114 other cell types or tissues.
DR   ExpressionAtlas; P27824; baseline and differential.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:AgBase.
DR   GO; GO:0044322; C:endoplasmic reticulum quality control compartment; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0098553; C:lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0033162; C:melanosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0044233; C:mitochondria-associated endoplasmic reticulum membrane contact site; IDA:MGI.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031965; C:nuclear membrane; IEA:Ensembl.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; TAS:Reactome.
DR   GO; GO:0072583; P:clathrin-dependent endocytosis; ISS:UniProtKB.
DR   GO; GO:0036503; P:ERAD pathway; IBA:GO_Central.
DR   GO; GO:0006457; P:protein folding; IBA:GO_Central.
DR   GO; GO:0034975; P:protein folding in endoplasmic reticulum; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0009306; P:protein secretion; TAS:ProtInc.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; ISS:UniProtKB.
DR   GO; GO:0019082; P:viral protein processing; TAS:Reactome.
DR   FunFam; 2.10.250.10:FF:000001; Calnexin homolog; 1.
DR   FunFam; 2.60.120.200:FF:000430; Si:ch211-274f20.2; 1.
DR   Gene3D; 2.60.120.200; -; 1.
DR   Gene3D; 2.10.250.10; Calreticulin/calnexin, P domain; 1.
DR   InterPro; IPR001580; Calret/calnex.
DR   InterPro; IPR018124; Calret/calnex_CS.
DR   InterPro; IPR009033; Calreticulin/calnexin_P_dom_sf.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   PANTHER; PTHR11073:SF11; CALNEXIN; 1.
DR   PANTHER; PTHR11073; CALRETICULIN AND CALNEXIN; 1.
DR   Pfam; PF00262; Calreticulin; 1.
DR   PRINTS; PR00626; CALRETICULIN.
DR   SUPFAM; SSF49899; Concanavalin A-like lectins/glucanases; 2.
DR   SUPFAM; SSF63887; P-domain of calnexin/calreticulin; 1.
DR   PROSITE; PS00803; CALRETICULIN_1; 1.
DR   PROSITE; PS00804; CALRETICULIN_2; 1.
DR   PROSITE; PS00805; CALRETICULIN_REPEAT; 3.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Calcium; Chaperone;
KW   Direct protein sequencing; Disulfide bond; Endoplasmic reticulum;
KW   Host-virus interaction; Lectin; Lipoprotein; Membrane; Metal-binding;
KW   Mitochondrion; Palmitate; Phosphoprotein; Proteomics identification;
KW   Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255, ECO:0007744|PubMed:25944712"
FT   CHAIN           21..592
FT                   /note="Calnexin"
FT                   /id="PRO_0000004198"
FT   TOPO_DOM        21..481
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        482..502
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        503..592
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REPEAT          278..290
FT                   /note="1-1"
FT   REPEAT          295..307
FT                   /note="1-2"
FT   REPEAT          314..326
FT                   /note="1-3"
FT   REPEAT          333..345
FT                   /note="1-4"
FT   REPEAT          348..358
FT                   /note="2-1"
FT   REPEAT          367..377
FT                   /note="2-2"
FT   REPEAT          381..391
FT                   /note="2-3"
FT   REPEAT          395..405
FT                   /note="2-4"
FT   REGION          260..345
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          276..409
FT                   /note="P domain (Extended arm)"
FT                   /evidence="ECO:0000250"
FT   REGION          278..345
FT                   /note="4 X approximate repeats"
FT   REGION          326..359
FT                   /note="Interaction with PPIB"
FT                   /evidence="ECO:0000250"
FT   REGION          348..405
FT                   /note="4 X approximate repeats"
FT   REGION          503..592
FT                   /note="Sufficient to mediate interaction with SGIP1"
FT                   /evidence="ECO:0000250"
FT   REGION          511..592
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        274..319
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        323..345
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        525..547
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         74
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P24643"
FT   BINDING         117
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P24643"
FT   BINDING         164
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         166
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         185
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         192
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         425
FT                   /ligand="an alpha-D-glucoside"
FT                   /ligand_id="ChEBI:CHEBI:22390"
FT                   /evidence="ECO:0000250|UniProtKB:P14211"
FT   BINDING         436
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P24643"
FT   MOD_RES         137
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         554
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18088087, ECO:0007744|PubMed:18318008,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         562
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         564
FT                   /note="Phosphoserine; by MAPK3"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         583
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18088087, ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   LIPID           502
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:22314232"
FT   LIPID           503
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:22314232"
FT   DISULFID        160..194
FT                   /evidence="ECO:0000250|UniProtKB:P24643"
FT   DISULFID        360..366
FT                   /evidence="ECO:0000250|UniProtKB:P24643"
FT   VAR_SEQ         1..108
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055515"
FT   VAR_SEQ         1
FT                   /note="M -> MADRRTPTPFAGCRLPRQRRARDASQVSAPGTRRIM (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055516"
FT   CONFLICT        179
FT                   /note="F -> L (in Ref. 2; AAA21749)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        431..433
FT                   /note="SDI -> LTF (in Ref. 10; AAA35696)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        480
FT                   /note="R -> L (in Ref. 10; AAA35696)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   592 AA;  67568 MW;  EDE094D9B82261EE CRC64;
     MEGKWLLCML LVLGTAIVEA HDGHDDDVID IEDDLDDVIE EVEDSKPDTT APPSSPKVTY
     KAPVPTGEVY FADSFDRGTL SGWILSKAKK DDTDDEIAKY DGKWEVEEMK ESKLPGDKGL
     VLMSRAKHHA ISAKLNKPFL FDTKPLIVQY EVNFQNGIEC GGAYVKLLSK TPELNLDQFH
     DKTPYTIMFG PDKCGEDYKL HFIFRHKNPK TGIYEEKHAK RPDADLKTYF TDKKTHLYTL
     ILNPDNSFEI LVDQSVVNSG NLLNDMTPPV NPSREIEDPE DRKPEDWDER PKIPDPEAVK
     PDDWDEDAPA KIPDEEATKP EGWLDDEPEY VPDPDAEKPE DWDEDMDGEW EAPQIANPRC
     ESAPGCGVWQ RPVIDNPNYK GKWKPPMIDN PSYQGIWKPR KIPNPDFFED LEPFRMTPFS
     AIGLELWSMT SDIFFDNFII CADRRIVDDW ANDGWGLKKA ADGAAEPGVV GQMIEAAEER
     PWLWVVYILT VALPVFLVIL FCCSGKKQTS GMEYKKTDAP QPDVKEEEEE KEEEKDKGDE
     EEEGEEKLEE KQKSDAEEDG GTVSQEEEDR KPKAEEDEIL NRSPRNRKPR RE
//
